{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-019892","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.480989+00:00","generated_at":"2026-05-18T06:15:14.877941+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BriaCell closes $15M public offering of 12M units at $1.25/unit","bullets":["Gross proceeds of $15M before fees; 12,000,000 units sold at $1.25 per unit.","Each unit comprises one common share (or pre-funded warrant at $0.001) and one warrant exercisable at $1.50 for five years.","ThinkEquity acted as sole placement agent; cash fee of 7.5% of gross proceeds.","Net proceeds earmarked for working capital, general corporate purposes, and advancement of business objectives.","Relies on TSX exemption for interlisted issuers; no Canadian prospectus filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-019892","json":"https://secwatch.observer/filing/0001641172-25-019892.json","markdown":"https://secwatch.observer/filing/0001641172-25-019892.md","text":"https://secwatch.observer/filing/0001641172-25-019892.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000164117225019892/0001641172-25-019892-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000164117225019892/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:15:14.877941+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}